ICBMT 2025

HOME

Scientific Program

SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

[JS05] Joint Symposium 5 (ISCT-KSBMT): Bridging Cell Therapy and Hematopoietic Stem Cell Transplantation

September 13 (Sat), 09:00-10:30 		Room A
Chair(s) TBD
  • William Hwang

    09:00-09:30

    Going Beyond Conventional CAR T Cell Therapies for Treatment of Blood Cancer and Other Diseases

    William Hwang

    Duke-NUS Medical School, Singapore

    CV
  • Seok-Goo Cho

    09:30-10:00

    Virus-Specific T-Cell Therapy: The Ultimate Weapon in the Endless Battle Against Post-Transplant Viral Infections

    Seok-Goo Cho

    College of Medicine, The Catholic University of Korea, Korea

    CV
  • TBD

    10:00-10:30

    MSC Treatment in HSCT and GVHD

    TBD

[SS09] Scientific Session 9: Navigating Critical HSCT Complications

September 13 (Sat), 09:00-10:30 		Room C
Chair(s) TBD
  • Souichi Shiratori

    09:00-09:30

    Diagnostic Imaging for Sinusoidal Obstruction Syndrome (SOS), including the Use of Liver Elastography

    Souichi Shiratori

    Hokkaido University Faculty of Medicine, Japan

    CV
  • Sonata Jodele

    09:30-10:00

    Diagnosis and Management of TA-TMA

    Sonata Jodele

    Cincinnati Children’s Hospital Medical Center, USA

    CV
  • Raeseok Lee

    10:00-10:30

    Post-HSCT Viral Management: Strategies Beyond the Guidelines

    Raeseok Lee

    College of Medicine, The Catholic University of Korea, Korea

    CV

[SS10] Scientific Session 10: Immunotherapy and Transplantation in Myeloid Malignancies: Evolving Strategies and Clinical Advances

September 13 (Sat), 09:00-10:30 		Room D
Chair(s) TBD
  • Musa Yilmaz

    09:00-09:30

    Evolving Paradigms in AML: How Transplantation Fits in the Modern Therapeutic Landscape

    Musa Yilmaz

    The University of Texas MD Anderson Cancer Center, USA

    CV
  • Amer M. Zeidan

    09:30-10:00

    Immune Checkpoint Modulation in Myeloid Malignancies: Will We Find Success Soon?

    Amer M. Zeidan

    Yale Cancer Center, USA

    CV
  • Junshik Hong

    10:00-10:30

    Augmenting NK-cell Immunity for the Treatment of Myeloid Malignancies using Hypomethylating Agents

    Junshik Hong

    Seoul National University College of Medicine, Korea

    CV

[JS06] Joint Symposium 6 (TSBMT-KSBMT): Chronic GVHD or Rare Transplantation Related Complications

September 13 (Sat), 10:40-11:40 		Room A
Chair(s) TBD
  • TBD

    10:40-11:10

    Pathophysiology and Management of Chronic GVHD

    TBD

  • Jin Kyung Suh

    11:10-11:40

    Rare Transplantation-related Cardiac or Neurological Complications

    Jin Kyung Suh

    University of Ulsan College of Medicine, Korea

[SS11] Scientific Session 11: Maximizing MM Treatment: Integrating Transplantation, Maintenance, and Novel Immunotherapies

September 13 (Sat), 10:40-12:10 		Room C
Chair(s) TBD
  • Thierry Facon

    10:40-11:10

    Do We Need ASCT for MM Patients in the New Agent Era?

    Thierry Facon

    Lille University Hospital, France

    CV
  • Evren Alici

    11:10-11:40

    Autologous NK Cell Therapy as a Consolidative Strategy after Auto-SCT

    Evren Alici

    Karolinska University Hospital, Sweden

    CV
  • Jongheon Jung

    11:40-12:10

    The Role of Salvage Auto-HSCT in RRMM Patients

    Jongheon Jung

    National Cancer Center, Korea

[NS02] Nursing Session 2: Multidisciplinary Approach to Treatment after Hematopoietic Stem Cell Transplantation ll (KOR.)

September 13 (Sat), 10:40-11:40 		Room D
Chair(s) Heejun Kim (Samsung Medical Center, Korea)
  • Pil Soo Sung

    10:40-11:10

    How Can We Reduce Liver-related Morbidity and Mortality in Patients after HSCT?

    Pil Soo Sung

    College of Medicine, The Catholic University of Korea, Korea

    CV
  • Jusik Kim

    11:10-11:40

    Practical Oral Care for HSCT

    Jusik Kim

    Seoul National University College of Medicine, Korea

    CV